Physician profile
David Berry
NPI 1437239613
$693.41
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2021: $117 · 2022: $57.53 · 2023: $87.13 · 2024: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $247.61 | 2023-2024 | Qelbree, Qelbree |
| Abbvie INC. | $104.47 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Coopersurgical, INC. | $65.18 | 2019-2023 | Paragard T 380a |
| Therapeuticsmd, INC. | $58.22 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $40.49 | 2024 | |
| Avion Pharmaceuticals | $26.46 | 2019 | |
| Merck Sharp & Dohme LLC | $22.13 | 2021 | |
| Ferring Pharmaceuticals INC. | $22.07 | 2019 | |
| Evofem Biosciences, INC. | $21.79 | 2021 | |
| Organon LLC | $20.90 | 2022 | |
| Astellas Pharma US INC | $20.62 | 2019 | |
| Roche Diagnostics Corporation | $19.07 | 2019 | |
| Hologic Sales and Service, LLC | $13.24 | 2019 | |
| Allergan, INC. | $11.16 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Berry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.